Utilizing pharmacokinetics/pharmacodynamics modeling to simultaneously examine free CCL2, total CCL2 and carlumab (CNTO 888) concentration time data. (Q30656754)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Utilizing pharmacokinetics/pharmacodynamics modeling to simultaneously examine free CCL2, total CCL2 and carlumab (CNTO 888) concentration time data.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23878055%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Utilizing pharmacokinetics/pharmacodynamics modeling to simultaneously examine free CCL2, total CCL2 and carlumab (CNTO 888) concentration time data (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23878055%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

pharmacodynamics

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

Shahneen K Sandhu

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23878055%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

author name string

Gerald J Fetterly

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23878055%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Urvi Aras

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23878055%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Patricia D Meholick

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23878055%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Chris Takimoto

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23878055%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Shobha Seetharam

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23878055%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Thomas McIntosh

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23878055%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Johann S de Bono

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23878055%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Anthony Tolcher

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23878055%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Hugh M Davis

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23878055%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Honghui Zhou

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23878055%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Thomas A Puchalski

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23878055%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

publication date

23 July 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23878055%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

number of pages

8

1 reference

based on heuristic

inferred from page(s)

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23878055%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

53

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23878055%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23878055%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1020-1027

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23878055%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

The human homolog of the JE gene encodes a monocyte secretory protein

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.140

21 January 2018

Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.140

21 January 2018

Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.140

21 January 2018

Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human esophageal squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.140

21 January 2018

Paracrine angiogenic loop between head-and-neck squamous-cell carcinomas and macrophages

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.140

21 January 2018

A key angiogenic role of monocyte chemoattractant protein-1 in hemangioendothelioma proliferation

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.140

21 January 2018

Tumour-educated macrophages promote tumour progression and metastasis

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.140

21 January 2018

Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.140

21 January 2018

CCL2 as an important mediator of prostate cancer growth in vivo through the regulation of macrophage infiltration

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.140

21 January 2018

Properties of a general PK/PD model of antibody-ligand interactions for therapeutic antibodies that bind to soluble endogenous targets

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.140

21 January 2018

Quasi-equilibrium pharmacokinetic model for drugs exhibiting target-mediated drug disposition.

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.140

21 January 2018

Relationship between omalizumab pharmacokinetics, IgE pharmacodynamics and symptoms in patients with severe persistent allergic (IgE-mediated) asthma.

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.140

21 January 2018

Identifiers

10.1002/JCPH.140

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23878055%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23878055%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30656754&oldid=1765243594"